|
NSA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.388000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.485570E-01 |
| Normal-vs-Stage2 |
4.710800E-01 |
| Normal-vs-Stage3 |
3.556800E-01 |
| Normal-vs-Stage4 |
5.464000E-01 |
| Stage1-vs-Stage2 |
8.434600E-01 |
| Stage1-vs-Stage3 |
6.267600E-01 |
| Stage1-vs-Stage4 |
4.775600E-01 |
| Stage2-vs-Stage3 |
9.372600E-01 |
| Stage2-vs-Stage4 |
7.855400E-01 |
| Stage3-vs-Stage4 |
7.775400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.196400E-01 |
| Normal-vs-AfricanAmerican |
5.175400E-01 |
| Normal-vs-Asian |
8.278900E-03 |
| Caucasian-vs-AfricanAmerican |
9.914600E-01 |
| Caucasian-vs-Asian |
1.902440E-02 |
| AfricanAmerican-vs-Asian |
1.294560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.155600E-01 |
| Normal-vs-Female |
2.732000E-01 |
| Male-vs-Female |
7.351000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.388370E-01 |
| Normal-vs-Age(41-60Yrs) |
3.108800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.215400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.402220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.057800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.326600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.595400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.884800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.079400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.632580E-01 |
| Classical-VS-Follicular |
6.530800E-01 |
| Classical-VS-Other |
7.567800E-01 |
| Classical-VS-Normal |
2.741000E-01 |
| Tall-VS-Follicular |
2.295600E-01 |
| Tall-VS-Other |
4.072200E-01 |
| Tall-VS-Normal |
6.576800E-01 |
| Follicular-VS-Other |
9.381200E-01 |
| Follicular-VS-Normal |
2.358200E-01 |
| Other-VS-Normal |
4.517400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.217950E-01 |
| Normal-vs-N1 |
1.046230E-01 |
| N0-vs-N1 |
6.801400E-01 |
|
|
